Product Information
GS ASPIRIN 81 MG CHEWABLE TAB is a generic product labeled by L. Perrigo Company, priced at $0.0248 per EA under NDC 00113027408. Its NADAC has been published 17 times since Mar 12, 2025.
Strength
81 mg/1
Manufacturer
L. Perrigo CompanyNDC
00113027408
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
6/18/2025
Active Ingredients
ASPIRINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
8/8/1997
Pharmacological Classes
Price Statistics
The NADAC for GS ASPIRIN 81 MG CHEWABLE TAB has been published 17 times since Mar 12, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0248 per EA |
|---|---|
| All-time high | $0.0261 (Apr 16, 2025) |
| All-time low | $0.0248 (Jun 18, 2025) |
| Median price | $0.0253 |
| Average price | $0.0254 |
| Largest weekly change | +4.1% (Mar 19, 2025) |
| Weeks tracked | 17 |
| Tracking since | Mar 12, 2025 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-1.0%
Last surveyed Jul 2, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aspirin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS ASPIRIN 81 MG CHEWABLE TAB?
The current National Average Drug Acquisition Cost (NADAC) for GS ASPIRIN 81 MG CHEWABLE TAB, manufactured by L. Perrigo Company, is $0.0248 per EA (NDC 00113027408), effective Jul 2, 2025.
How has the price of GS ASPIRIN 81 MG CHEWABLE TAB changed over time?
Over the history we have for it, the NADAC for GS ASPIRIN 81 MG CHEWABLE TAB has held within roughly two percent of its current level. It has been tracked across 17 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for GS ASPIRIN 81 MG CHEWABLE TAB?
Since Mar 12, 2025, the NADAC for GS ASPIRIN 81 MG CHEWABLE TAB has ranged from a low of $0.0248 (Jun 18, 2025) to a high of $0.0261 (Apr 16, 2025), with a median of $0.0253 per EA.
Are there cheaper alternatives to GS ASPIRIN 81 MG CHEWABLE TAB?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MINIPRIN EC 81 MG TABLET, is $0.0118 per EA — about 52% below GS ASPIRIN 81 MG CHEWABLE TAB.
Who manufactures GS ASPIRIN 81 MG CHEWABLE TAB?
GS ASPIRIN 81 MG CHEWABLE TAB (NDC 00113027408) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.